International cooperation
The Saudi delegation made a strong presence at the 2025 BIO International Convention, with a national pavilion led by the Ministry of Health. This event is part of the broader efforts to strengthen international cooperation and position Saudi Arabia as a leading regional hub for biotechnology. The pavilion features more
International cooperation
As the global biotech industry converges at the Boston Convention & Exhibition Center from June 16 to 19, a delegation of 16 Hong Kong life science and health technology companies, led by the Hong Kong Government's InvestHK, will showcase the city's cutting-edge biotech ecosystem. This joint
Securities law
Adaptive Biotechnologies Corporation, a leader in next-generation immunosequencing, has filed a Form 8-K with the US Securities and Exchange Commission (SEC) on June 12, 2025, detailing the results of its annual meeting of shareholders held on June 10, 2025. The meeting saw significant voting participation, with three proposals presented to
Biotechnology
SyntecBio inc has emerged as a standout opportunity for investors seeking high-growth potential in the biopharma sector, which continues to grow at an impressive 7.4% annually. Leveraging cutting-edge innovation and a robust research pipeline, SyntecBio positions itself at the forefront of next-generation therapeutics. Founded in 2016, the company focuses
Securities law
Sana Biotechnology, Inc. recently filed a Form 8-K (Current Report) with the U.S. Securities and Exchange Commission on June 6, 2025, announcing the outcome of its 2025 annual meeting of stockholders. The meeting took place on June 5, 2025, and addressed several proposals submitted to a vote of the
Biotechnology
The company, PURSUANT TO THE AUTHORITY GRANTED at the General Meeting of the Company held on 27 February 2025, has made a market purchase of its own shares. The company has purchased a total of 50,000 ordinary shares of 25p each, which will be cancelled. This purchase brings the
Biotechnology
A notification has been made by Frostrow Capital LLP on behalf of the company, stating that it has made a market purchase of its own shares. The company had been granted authority at its General Meeting held on 27 February 2025 to make these purchases, with a maximum aggregate total
Biotechnology
The Biotech Growth Trust PLC has disclosed that it has acquired a total of 155,562 of its own Ordinary shares as part of its authority to make market purchases of its shares up to a maximum of 4,255,299. This move is aimed at reducing the Company'
Biotechnology
Rossari Biotech, a leading specialty chemicals manufacturing company in India, has received approval from its Board of Directors to expand its capacity by 13,000 Metric Tons Per Annum (MTPA) in a phased manner. This expansion is expected to be completed by the 4th Quarter of FY 2025-26, with an
Biotechnology
Rossari Global DMCC has established a step-down wholly owned subsidiary, Rossari Biotech Trading FZE, with a primary focus on trading and manufacturing activities, including the distribution and sales of chemicals and consumer products for export markets. This move marks an expansion of Rossari Biotech's operations, leveraging its position
Biotechnology
The Employees Provident Fund Board has acquired an additional 100,000 shares in Duopharma Biotech Berhad, increasing its indirect stake in the company to 8.874%. The acquisition was made on September 3, 2024, through Citigroup Nominees (Tempatan) Sdn. Bhd. The Employees Provident Fund Board now holds a total of
Biotechnology
Trinity Biotech plc, a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, announced its Q2 2024 financial results today. The company reported strong revenue and profitability improvements, driven by the TrinScreen HIV business. The company's existing business segments, including TrinScreen HIV
